EUVIMEDEUVIMED entdecken
Open Access

Intelligent biosensing and point-of-care testing: from molecular recognition to decentralized precision care

Jixi Zhang, Yi Zhang

Journal of Zhejiang University-SCIENCE B · 2026-07 · 27 (7) · 671-676

DOI: 10.1631/jzus.b2610002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Zhejiang University-SCIENCE B, online erschienen am 04.08.2026. Verfasst von Jixi Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400044, Ch…. Hauptthemen laut MEDLINE: Point-of-Care Testing, Biosensing Techniques, Precision Medicine. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Point-of-care testing (POCT) is changing the way diagnostic information is generated, interpreted, and used.Its value extends well beyond shortening turnaround time.A meaningful POCT result should support a defined clinical or public-health action, such as early triage, treatment selection, disease surveillance, referral, or longitudinal follow-up.In this sense, POCT is best understood as a distributed extension of laboratory medicine rather than a simplified replacement for the central laboratory (Banfi et al., 2024;Plebani et al., 2025).The need for decentralized testing is becoming increasingly apparent.Diagnostic demand continues to rise everywhere, while specialized instruments, laboratory expertise, and confirmatory capacity remain concentrated in major hospitals.Patients in community settings may face delayed diagnosis, repeated travel, or empirical treatment.Similar gaps exist in food safety, environmental monitoring, and outbreak control, where decisions must often be made before samples can reach a centralized laboratory.However, moving a test closer to the user introduces its own set of challenges related to sampling, reagent storage, operator variation, data transfer, quality assurance, and clinical interpretation.The development of POCT therefore requires a balance between analytical innovation and real-world reliability.This special issue on "Intelligent Biosensing and Point-of-Care Testing (POCT)" brings together eight articles that cover material-enhanced lateral flow assays, one-pot nucleic acid testing, bacterial pathogen detection, functional genetic diagnostics, biomarker-based disease stratification, microphysiological models, molecular imaging, programmable DNAzyme systems, and precision neurology.These articles address different stages of the translational pathway, from molecular recognition and signal generation to algorithmic interpretation and clinical application.Together, they show that the future of POCT will be shaped not by a single device format, but by deep integration of chemistry, materials science, molecular biology, engineering, artificial intelligence (AI), and laboratory medicine. Materials-enabled rapid testsLateral flow assays remain the most widely used POCT format, owing to their low cost and speed, self-contained nature, and ease of use.Yet the apparent simplicity of a test strip often conceals important limitations, including low analytical sensitivity interference from sample matrices and limited multiplexing capacity.Improvements in recognition probes, nanoparticle labels, membranes, optical readers, and signalprocessing strategies have therefore become central to the evolution of lateral flow biosensors (Yetisen et al., 2013;Quesada-González and Merkoçi, 2015).In this issue, Ding et al. (2026) illustrated the movement from open-tube molecular testing toward integrated workflows.Their one-pot TLAMP-PfAgo assay (OTPA) combines turn-back loop primeraccelerated loop-mediated isothermal amplification (LAMP) (TLAMP) with the sequence-specific cleavage

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Point-of-Care TestingBiosensing TechniquesPrecision MedicineHumansPoint-of-Care SystemsRapid Diagnostic Tests

Autor:innen und Institutionen

  • Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400044, China.
  • Laboratory Medicine Center Department of Transfusion Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310014, China. zhangyi8310@sina.com.

Zitieren

APA

Zhang, J., & Zhang, Y. (2026). Intelligent biosensing and point-of-care testing: from molecular recognition to decentralized precision care. Journal of Zhejiang University-SCIENCE B, 27(7), 671-676. https://doi.org/10.1631/jzus.b2610002

Vancouver

Zhang J, Zhang Y. Intelligent biosensing and point-of-care testing: from molecular recognition to decentralized precision care. Journal of Zhejiang University-SCIENCE B. 2026;27(7):671-676. doi:10.1631/jzus.b2610002

BibTeX
@article{Zhang2026,
  author = {Zhang, Jixi and Zhang, Yi},
  title = {Intelligent biosensing and point-of-care testing: from molecular recognition to decentralized precision care},
  journal = {Journal of Zhejiang University-SCIENCE B},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {671--676},
  doi = {10.1631/jzus.b2610002}
}
Kostenlos starten →